Y-mAbs Therapeutics
World Rank (Jan-05-2024)
15,784
Market Cap (Jan-05-2024)
0.299 Billion USD
World Rank (Jul-30-2023)
16,389
Market Cap (Jul-30-2023)
0.273 Billion USD
World Rank (Dec-25-2022)
18,010
Market Cap (Dec-25-2022)
0.200 Billion USD
World Rank (Jan-07-2022)
12,185
Market Cap (Jan-07-2022)
0.61 Billion USD
Annual Revenue in USD
34 Million USD
Annual Net Income in USD
-55 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Company Profile
Y-mAbs Therapeutics is a Late Stage Clinical Biopharmaceutical company. It is focused on the development and commercialization of novel, antibody based therapeutic products for the treatment of cancer. The headquarters is in USA.
Company Website